The formation of Neurosterix with a substantial investment and the contribution of Addex's assets are likely to be viewed positively by the market. The financial gain and equity stake in Neurosterix could provide Addex with a significant upside, especially if the venture's focus on neurological disorders leads to successful therapeutic developments. This strategic move not only brings immediate financial benefit but also aligns Addex with a promising new venture in a critical area of medicine, potentially enhancing its market position and future revenue prospects.